These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 31772069)

  • 1. Cystic Fibrosis Lung Disease: An Overview.
    Turcios NL
    Respir Care; 2020 Feb; 65(2):233-251. PubMed ID: 31772069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model of mucociliary clearance in cystic fibrosis lungs.
    Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
    J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Airway mucus in cystic fibrosis.
    Puchelle E; Bajolet O; Abély M
    Paediatr Respir Rev; 2002 Jun; 3(2):115-9. PubMed ID: 12297057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease.
    Gehrig S; Duerr J; Weitnauer M; Wagner CJ; Graeber SY; Schatterny J; Hirtz S; Belaaouaj A; Dalpke AH; Schultz C; Mall MA
    Am J Respir Crit Care Med; 2014 May; 189(9):1082-92. PubMed ID: 24678594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis.
    Hoegger MJ; Fischer AJ; McMenimen JD; Ostedgaard LS; Tucker AJ; Awadalla MA; Moninger TO; Michalski AS; Hoffman EA; Zabner J; Stoltz DA; Welsh MJ
    Science; 2014 Aug; 345(6198):818-22. PubMed ID: 25124441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis.
    Elborn JS
    Lancet; 2016 Nov; 388(10059):2519-2531. PubMed ID: 27140670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Airway clearance strategies in cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Main E; Grillo L; Rand S
    Semin Respir Crit Care Med; 2015 Apr; 36(2):251-66. PubMed ID: 25826592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively?
    Tiddens HA; Donaldson SH; Rosenfeld M; Paré PD
    Pediatr Pulmonol; 2010 Feb; 45(2):107-17. PubMed ID: 20082341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy.
    Boucher RC
    Annu Rev Med; 2007; 58():157-70. PubMed ID: 17217330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucociliary Transport in Healthy and Cystic Fibrosis Pig Airways.
    Xie Y; Ostedgaard L; Abou Alaiwa MH; Lu L; Fischer AJ; Stoltz DA
    Ann Am Thorac Soc; 2018 Nov; 15(Suppl 3):S171-S176. PubMed ID: 30431346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New concepts of the pathogenesis of cystic fibrosis lung disease.
    Boucher RC
    Eur Respir J; 2004 Jan; 23(1):146-58. PubMed ID: 14738247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics.
    Kunzelmann K; Mall M
    Am J Respir Med; 2003; 2(4):299-309. PubMed ID: 14719996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of the pathogenesis of cystic fibrosis lung disease.
    Boucher RC
    Adv Drug Deliv Rev; 2002 Dec; 54(11):1359-71. PubMed ID: 12458149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatories and mucociliary clearance therapies in the age of CFTR modulators.
    Perrem L; Ratjen F
    Pediatr Pulmonol; 2019 Nov; 54 Suppl 3():S46-S55. PubMed ID: 31715088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losartan Rescues Inflammation-related Mucociliary Dysfunction in Relevant Models of Cystic Fibrosis.
    Kim MD; Baumlin N; Yoshida M; Polineni D; Salathe SF; David JK; Peloquin CA; Wanner A; Dennis JS; Sailland J; Whitney P; Horrigan FT; Sabater JR; Abraham WM; Salathe M
    Am J Respir Crit Care Med; 2020 Feb; 201(3):313-324. PubMed ID: 31613648
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis.
    Mortensen J; Hansen A; Falk M; Nielsen IK; Groth S
    Chest; 1993 Mar; 103(3):805-11. PubMed ID: 8095449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH.
    Hill DB; Long RF; Kissner WJ; Atieh E; Garbarine IC; Markovetz MR; Fontana NC; Christy M; Habibpour M; Tarran R; Forest MG; Boucher RC; Button B
    Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30361244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease.
    Matsui H; Grubb BR; Tarran R; Randell SH; Gatzy JT; Davis CW; Boucher RC
    Cell; 1998 Dec; 95(7):1005-15. PubMed ID: 9875854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
    Mall MA
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.